Glass House Brands (GLAS) Inventory Average (2021 - 2026)
Glass House Brands (GLAS) posted quarterly Inventory Average of $28.9 million for Q1 2026, up 92.97% year-over-year from $15.0 million in Q1 2025, and up 26.67% quarter-over-quarter from $22.8 million in Q4 2025.
Glass House Brands (GLAS) Inventory Average (2021 - 2026) Analysis & Trends
Glass House Brands (GLAS) has reported Inventory Average for 6 consecutive years, with $28.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Inventory Average rose 92.97% year-over-year to $28.9 million; the TTM figure through Mar 2026 stood at $28.9 million (up 92.97% YoY), while the FY2025 annual figure was $20.2 million, up 75.29% from the prior year.
- Inventory Average rose to $28.9 million in Q1 2026 per GLAS's latest filing, from $22.8 million in the prior quarter.
- Across five years, Inventory Average topped out at $28.9 million in Q1 2026 and bottomed at $7.1 million in Q1 2022.
- Historically, Inventory Average has averaged $14.9 million across 5 years, with a median of $14.8 million in 2023.
- Annual changes were most pronounced in 2024 — Inventory Average fell 21.77% — and 2026, when it jumped 92.97%.
- Glass House Brands' Inventory Average stood at $11.8 million in 2022, then declined by 8.53% to $10.8 million in 2023, then soared by 43.09% to $15.5 million in 2024, then soared by 47.01% to $22.8 million in 2025, then climbed by 26.67% to $28.9 million in 2026.
- Business Quant data shows GLAS's Inventory Average at $28.9 million in Q1 2026, $22.8 million in Q4 2025, and $19.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 1.41 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 3.20 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 2.56 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 8.99 Bn |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 186.05 Mn |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 3.93 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 84.35 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 1.74 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 824.00 Mn |
| 10 | Glass House Brands | 830.21 Mn | 811.66 Mn | 15.77 Mn | 32.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28.88 Mn |
| Dec 31, 2025 | 22.80 Mn |
| Sep 30, 2025 | 19.52 Mn |
| Jun 30, 2025 | 17.68 Mn |
| Mar 31, 2025 | 14.97 Mn |
| Dec 31, 2024 | 15.51 Mn |
| Sep 30, 2024 | 15.64 Mn |
| Jun 30, 2024 | 12.86 Mn |
| Mar 31, 2024 | 10.03 Mn |
| Dec 31, 2023 | 10.84 Mn |
| Sep 30, 2023 | 14.77 Mn |
| Jun 30, 2023 | 15.69 Mn |
| Mar 31, 2023 | 12.82 Mn |
| Dec 31, 2022 | 11.85 Mn |
| Sep 30, 2022 | 12.50 Mn |
| Jun 30, 2022 | 9.93 Mn |
| Mar 31, 2022 | 7.06 Mn |
| Dec 31, 2021 | 8.94 Mn |
| Sep 30, 2021 | 11.46 Mn |
| Jun 30, 2021 | 10.20 Mn |